- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Trends in biotechnology 42, 12, S. 1663-1667
- Ereignis
-
Veröffentlichung
- (wo)
-
Saarbrücken
- (wer)
-
Leibniz-Institut für Neue Materialien
- (wann)
-
2024
- Urheber
- DOI
-
10.1016/j.tibtech.2024.06.011
- URN
-
urn:nbn:de:bsz:291:415-10772
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dey, Sourik
- Sankaran, Shrikrishnan
- Leibniz-Institut für Neue Materialien
Entstanden
- 2024
Ähnliche Objekte (12)
Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer
In vitro-engineered non-antibody protein therapeutics
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
The Application of Engineered Nanomaterials in Perinatal Therapeutics
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics
Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics
Natural and engineered bacterial outer membrane vesicles
Single Atom Engineered Antibiotics Overcome Bacterial Resistance
Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics
Plasmonic Material Engineering for Targeted Therapeutics
Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer
In vitro-engineered non-antibody protein therapeutics
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
The Application of Engineered Nanomaterials in Perinatal Therapeutics
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics
Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics
Natural and engineered bacterial outer membrane vesicles
Single Atom Engineered Antibiotics Overcome Bacterial Resistance
Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics
Plasmonic Material Engineering for Targeted Therapeutics
Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer
In vitro-engineered non-antibody protein therapeutics
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
The Application of Engineered Nanomaterials in Perinatal Therapeutics
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking
Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics
Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics
Natural and engineered bacterial outer membrane vesicles
Single Atom Engineered Antibiotics Overcome Bacterial Resistance
Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics